Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY12.69 CNY
Change Today -1.40 / -9.94%
Volume 10.4M
As of 3:00 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

lanzhou foci pharmaceutica-a (002644) Snapshot

Open
CNY12.74
Previous Close
CNY14.09
Day High
CNY14.49
Day Low
CNY12.68
52 Week High
08/12/15 - CNY27.20
52 Week Low
01/5/15 - CNY7.49
Market Cap
6.5B
Average Volume 10 Days
14.2M
EPS TTM
CNY0.08
Shares Outstanding
510.7M
EX-Date
06/24/15
P/E TM
162.7x
Dividend
CNY0.0064
Dividend Yield
0.05%
Current Stock Chart for LANZHOU FOCI PHARMACEUTICA-A (002644)

Related News

No related news articles were found.

lanzhou foci pharmaceutica-a (002644) Related Businessweek News

No Related Businessweek News Found

lanzhou foci pharmaceutica-a (002644) Details

Lanzhou Foci Pharmaceutical Co., Ltd. manufactures and distributes traditional Chinese medicines, western drugs, and raw herbs in China. It offers antibiotics and products for gastrointestinal disorders and gynecological problems, as well as pediatric products. The company provides its products in various dosage forms, including pills, tablets, granules, capsules, concentrated decoctions, mixtures, oral liquids, syrups, and medicinal wines under the Min Shan and Foci brand. Lanzhou Foci Pharmaceutical Co., Ltd. exports its products to approximately 27 countries and areas, which include the United States, the United Kingdom, Canada, Japan, Singapore, Indonesia, Thailand, Malaysia, Germany, the Netherlands, New Zealand, Australia, Russia, Ukraine, and Hong Kong. The company was founded in 1929 and is based in Lanzhou, China.

Founded in 1929

lanzhou foci pharmaceutica-a (002644) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lanzhou foci pharmaceutica-a (002644) Key Developments

Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Amendments to Articles of Association

Lanzhou Foci Pharmaceutical Co.,Ltd. approved amendments to the company's articles of association, at its extraordinary general meeting of 2015 held on August 5, 2015.

Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Amendments to Articles of Association

Lanzhou Foci Pharmaceutical Co.,Ltd. proposed amendments to the company's articles of association, to its extraordinary general meeting of 2015 to be held on August 5, 2015.

Lanzhou Foci Pharmaceutical Co.,Ltd., Special/Extraordinary Shareholders Meeting, Aug 05, 2015

Lanzhou Foci Pharmaceutical Co.,Ltd., Special/Extraordinary Shareholders Meeting, Aug 05, 2015., at 14:00 China Standard Time. Agenda: To approve 2015 interim profit distribution plan; and to approve amendments to the company's articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002644:CH CNY12.69 CNY -1.40

002644 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002644.
View Industry Companies
 

Industry Analysis

002644

Industry Average

Valuation 002644 Industry Range
Price/Earnings 100.0x
Price/Sales 20.3x
Price/Book 5.8x
Price/Cash Flow 185.6x
TEV/Sales 18.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANZHOU FOCI PHARMACEUTICA-A, please visit www.fczy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.